Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Asset Acquisition [Table] Asset Acquisition [Table] Maximum milestone payments for licensed products Research and Development Arrangement, Contract to Perform for Others, Product Milestone Payments Research and Development Arrangement, Contract to Perform for Others, Product Milestone Payments Statistical Measurement [Domain] Statistical Measurement [Domain] Reportable Segment Reportable Segment [Member] Reportable Segment Title of 12(b) Security Title of 12(b) Security Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Document Fiscal Year Focus Document Fiscal Year Focus Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Number of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Consideration transferred Asset Acquisition, Consideration Transferred, Gross Asset Acquisition, Consideration Transferred, Gross Schedule of Fair Value of Assets Measured on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Common stock, $0.0001 par value; 300,000 shares authorized at June 30, 2026 and December 31, 2025; 125,591 and 123,333 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Accrued compensation Employee-related Liabilities, Current Schedule of Debt Schedule of Long-Term Debt Instruments [Table Text Block] Award requisite service period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Other prepaid expenses and current assets Other Prepaid Expense, Current Restatement Determination Date Restatement Determination Date Accrued Ducentis milestone Asset Acquisition, Payments, Milestones, Or Royalties, Future Payable Amount Asset Acquisition, Payments, Milestones, Or Royalties, Future Payable Amount Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Loan Agreement, Tranche One, Expiring March 31, 2026 Loan Agreement, Tranche C-1, Expiring March 31, 2026 [Member] Loan Agreement, Tranche C-1, Expiring March 31, 2026 Warrants to acquire shares of common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Schedule of Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] Minimum net product revenue as a percentage of projected monthly net revenue Debt Instrument, Covenant, Minimum Net Product Revenue As A Percentage Of Projected Net Product Revenue Debt Instrument, Covenant, Minimum Net Product Revenue As A Percentage Of Projected Net Product Revenue Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Final fee (as percent) Debt Instrument, Final Fee, Percentage Debt Instrument, Final Fee, Percentage Masaru Matsuda [Member] Masaru Matsuda Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Unrealized losses Cash And Cash Equivalents, Unrealized Loss Cash And Cash Equivalents, Unrealized Loss Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent PEO Total Compensation Amount PEO Total Compensation Amount Revenue, remaining performance obligation, variable consideration amount, regulatory milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount, Regulatory Milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount, Regulatory Milestones Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Asset Acquisition [Axis] Asset Acquisition [Axis] Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted-average shares used in computing earnings (loss) per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net accretion on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Number of reportable segments Number of Reportable Segments Income (loss) before income taxes Income (Loss) Attributable to Parent, before Tax Total current liabilities Liabilities, Current Work in progress Inventory, Work in Process, Net of Reserves Product revenue, net Revenue from Contract with Customer, Including Assessed Tax Entity Address, City or Town Entity Address, City or Town Lessee, operating lease, office space Lessee, Operating Lease, Office Space Lessee, Operating Lease, Office Space Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Royalty expense Royalty Expense Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Issuance of shares of common stock for sales agreement Sale Of Stock, Authorized Consideration On Transaction Sale Of Stock, Authorized Consideration On Transaction Annual net sales Research and Development Arrangement, Contract to Perform for Others, Annual Worldwide Net Sales Threshold Research and Development Arrangement, Contract to Perform for Others, Annual Worldwide Net Sales Threshold Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Current portion of long-term debt, net Less current portion Long-Term Debt, Current Maturities Issuance of common stock upon the vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Default rate (as a percent) Debt Instrument, Default Rate Debt Instrument, Default Rate Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Segment Reporting Segment Reporting [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Total other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Exercise price (in USD per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Long-term debt Total carrying value of debt Long-Term Debt Maturing in one to five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Huadong Huadong [Member] Huadong ZORYVE cream 0.15% ZORYVE Cream 0.15% [Member] ZORYVE Cream 0.15% Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Future payable remaining amount Asset Acquisition, Payments, Milestones, Or Royalties, Future Payable Remaining Amount Asset Acquisition, Payments, Milestones, Or Royalties, Future Payable Remaining Amount Share sales agreement, percentage of gross sales price Sale Of Stock, Agent Fee, Percentage Of Gross Proceeds Sale Of Stock, Agent Fee, Percentage Of Gross Proceeds Earnings (loss) per share: Earnings Per Share, Basic [Abstract] Less: Costs and Expenses [Abstract] Security Exchange Name Security Exchange Name Effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Granted (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-average shares used in computing earnings (loss) per share: Earnings Per Share, Basic, Other Disclosure [Abstract] Loan Agreement, Tranche One, Expiring June 30, 2026 Loan Agreement, Tranche C-2, Expiring June 30, 2026 [Member] Loan Agreement, Tranche C-2, Expiring June 30, 2026 Total grant-date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Prepaid clinical trial costs Prepaid Clinical Trial Test Costs, Current Prepaid Clinical Trial Test Costs, Current Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Milestone amount paid Asset Acquisition, Payments, Milestones, Or Royalties, Paid Asset Acquisition, Payments, Milestones, Or Royalties, Paid Equity interest issued or issuable, number of shares (in shares) Asset Acquisition, Equity Interest Issued or Issuable, Number of Shares Asset Acquisition, Equity Interest Issued or Issuable, Number of Shares Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Earnings (Loss) Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Schedule of Weighted Average Number of Shares Schedule of Weighted Average Number of Shares [Table Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Tax withholding obligation Contract Not With Customer, Liability, Tax Withholding Obligation Contract Not With Customer, Liability, Tax Withholding Obligation Award Date [Axis] Award Date [Axis] Operating lease right-of-use asset Increase (Decrease) In Operating Lease, Right-of-Use Asset Increase (Decrease) In Operating Lease, Right-of-Use Asset Stock Option Exchange Stock Option Exchange [Member] Stock Option Exchange Interest rate, stated percentage, partial prepayment Debt Instrument, Interest Rate, Stated Percentage, Partial Prepayment Debt Instrument, Interest Rate, Stated Percentage, Partial Prepayment First Grant Date First Grant Date [Member] First Grant Date Long-term debt, gross Long-Term Debt, Gross CASH FLOWS FROM OPERATING ACTIVITIES: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Weighted-average shares used in computing earnings (loss) per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Number of years after first commercial sale to receive royalties License Agreement, Term License Agreement, Term Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] ZORYVE cream 0.3% ZORYVE Cream 0.3% [Member] ZORYVE Cream 0.3% Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Prefunded Warrant Prefunded Warrant [Member] Prefunded Warrant Commercial paper Commercial Paper [Member] U.S. Treasury and agency securities US Treasury Securities [Member] Award Date [Domain] Award Date [Domain] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revenue from Contract with Customer [Abstract] Todd Franklin Watanabe [Member] Todd Franklin Watanabe Award Timing Predetermined Award Timing Predetermined [Flag] Intrinsic value of options exercised during the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Debt Securities, Available-for-Sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Effect of dilutive securities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Beginning balance (in dollar per share) Ending balance (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Operating lease liability Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] ARQ-234 program costs ARQ-234 Program Costs [Member] ARQ-234 Program Costs Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Scenario [Domain] Scenario [Domain] Asset Acquisition [Domain] Asset Acquisition [Domain] Beginning balance, weighted-average exercise price (in dollar per share) Ending balance, weighted-average exercise price (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating lease right-of-use asset Operating Lease, Right-of-Use Asset Debt Instrument, Tranche [Axis] Debt Instrument, Tranche [Axis] Debt Instrument, Tranche Maturing within one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Tranche B-1 term loan Tranche B-1 Term Loan [Member] Tranche B-1 Term Loan Segment Reporting Segment Reporting [Text Block] Proceeds from maturities and sales of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Maturity, due 2029 Long-Term Debt, Maturity, Year Four Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Income Statement Location [Axis] Location, Statement of Income, Balance [Axis] Restricted cash Restricted Cash and Cash Equivalent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Money market funds Estimated fair value Cash and Cash Equivalents, Fair Value Disclosure Increase in future lease rent payment commitments Lessee, Operating Lease, Increase In Future Lease Rent Payment Commitments Lessee, Operating Lease, Increase In Future Lease Rent Payment Commitments Remaining Contractual Term (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Amortized cost Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract] Contingent payments remaining Asset Acquisition, Payments, Development, Regulatory And Commercial Milestones, Contingent Amount Remaining Asset Acquisition, Payments, Development, Regulatory And Commercial Milestones, Contingent Amount Remaining Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Other income (expense): Other Income and Expenses [Abstract] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Weighted-average common shares outstanding - Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted, Rounding Adjustment Weighted Average Number of Shares Outstanding, Diluted, Rounding Adjustment Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Intangible asset, useful life Intangible Asset, Finite-Lived, Useful Life Weighted-average common shares outstanding - Basic (in shares) Weighted Average Number of Shares Outstanding, Basic, Rounding Adjustment Weighted Average Number of Shares Outstanding, Basic, Rounding Adjustment Tranche C Term Loans Tranche C Term Loans [Member] Tranche C Term Loans License Agreements And Acquisitions License Agreements And Acquisitions [Text Block] License Agreements And Acquisitions Exercise Price Award Exercise Price CASH FLOWS FROM INVESTING ACTIVITIES: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Scenario [Axis] Scenario [Axis] Unamortized debt issuance costs Debt Issuance Costs, Net Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] Unrealized gains Cash And Cash Equivalents, Unrealized Gain Cash And Cash Equivalents, Unrealized Gain PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Secured debt Secured Debt [Member] Total operating expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ equity Beginning balance Ending Balance Equity, Attributable to Parent Percentage of eligible options exchanged Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Eligible Options Exchanged Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Eligible Options Exchanged Total other income (expense) Nonoperating Income (Expense) At-The-Market At-The-Market [Member] At-The-Market Deferred final fee Debt Instrument, Deferred Final Fee, Gross Debt Instrument, Deferred Final Fee, Gross ASSETS Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Debt Instrument, Fee Amount Debt Instrument, Fee Amount Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Insider Trading Policies and Procedures [Line Items] Beginning balance, number of options (in shares) Ending balance, number of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Selling, general and administrative Selling, general and administrative expenses Selling, General and Administrative Expense Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Prepaid co-pay assistance program and rebates Prepaid Copay Assistance Program And Rebates Prepaid Copay Assistance Program And Rebates Vested (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Potentially antidilutive shares excluded from the calculation of net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount RSUs subject to future vesting Restricted Stock Units (RSUs) [Member] Schedule of Potentially Dilutive Shares Excluded Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Number of years after first commercial sale to receive royalties License Agreement, Number Of Years After First Commercial Sale To Receive Royalties License Agreement, Number Of Years After First Commercial Sale To Receive Royalties Entity Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Research and development compensation and personnel-related expenses Research and development compensation and personnel-related expenses Research and development compensation and personnel-related expenses Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash provided by (used in) operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Sato Sato [Member] Sato Stockholders’ equity: Equity, Attributable to Parent [Abstract] Shares issued pursuant to the employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Other program costs Other Program Costs [Member] Other Program Costs Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Grant date fair value of options vested during the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Number of days for written notice License Agreement, Termination, Number Of Days For Written Notice License Agreement, Termination, Number Of Days For Written Notice City Area Code City Area Code Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liabilities Increase (Decrease) in Operating Lease Liabilities Name Forgone Recovery, Individual Name Finished goods Inventory, Finished Goods, Net of Reserves Recognized over a weighted-average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Assets Common stock reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Research and Development, Contract to Perform for Others [Table] Grant date fair value of options vested during the period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Interest expense Interest Expense, Nonoperating Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Accrued final fee Debt Instrument, Accrued Final Fee Debt Instrument, Accrued Final Fee Proceeds from issuance of common stock pursuant to employee stock purchase plan Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Stockholders' Equity Share-Based Payment Arrangement [Text Block] Shares issued pursuant to the employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan PEO PEO [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Expired (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total stock-based compensation expense Share-Based Payment Arrangement, Expense Other long-term liabilities Other Liabilities, Noncurrent Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Issuance of common stock upon the exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Accrued prepayment penalty Debt Instrument, Accrued Prepayment Penalty Debt Instrument, Accrued Prepayment Penalty Granted (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Maturing within one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Accumulated Deficit Retained Earnings [Member] Operating lease liability, long-term Operating Lease, Liability, Noncurrent Money market funds and cash Money Market Funds [Member] Forfeited (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurement Fair Value Measurement, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Unrealized gain (loss) on marketable securities Unrealized gain (loss) on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Corporate debt securities Corporate Debt Securities [Member] Earnings (loss) per share, diluted (in USD per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Amortization of intangible assets Intangible Asset, Finite-Lived, Amortization Expense Tranche A term loan Tranche A Term Loan [Member] Tranche A Term Loan Research and development Research and Development Expense Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-Based Payment Arrangement [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property, plant, and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization After December 22, 2023 and prior to December 22, 2025 Debt Instrument, Redemption, Period Three [Member] Financial Instruments [Domain] Financial Instruments [Domain] License Agreements And Acquisition Disclosure [Abstract] License Agreements And Acquisition Disclosure AstraZeneca AstraZeneca [Member] AstraZeneca Issuance of common stock upon the exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Todd Frank Watanabe [Member] Todd Frank Watanabe Revenues Revenue from Contract with Customer [Text Block] Forfeited (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cowen Cowen And Company LLC [Member] Cowen And Company LLC Exit fee expiration period (in years) Debt Instrument, Exit Fee, Expiration Period Debt Instrument, Exit Fee, Expiration Period Inventory Increase (Decrease) in Inventories Periodic principal payment Debt Instrument, Periodic Payment, Principal Tranche B-2 term loan Tranche B-2 Term Loan [Member] Tranche B-2 Term Loan Topical roflumilast program costs Topical Roflumilast Program [Member] Topical Roflumilast Program Segment Reporting [Table] Segment Reporting [Table] Shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Sale of Stock [Axis] Sale of Stock [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] ZORYVE cream 0.05% ZORYVE cream 0.05% [Member] ZORYVE cream 0.05% Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Income (loss) from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt instrument, prepayment penalty Debt Instrument, Prepayment Penalty Debt Instrument, Prepayment Penalty Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Aggregate amount to be received upon achievement of sales milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount, Sales Milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount, Sales Milestones Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Incremental cost of plan modification Share-Based Payment Arrangement, Plan Modification, Incremental Cost Allowance for credit loss Debt Securities, Available-for-Sale, Allowance for Credit Loss Ducentis Biotherapeutics LTD Equity Interests Ducentis Biotherapeutics LTD Equity Interests [Member] Ducentis Biotherapeutics LTD Equity Interests Marketable securities Debt Securities, Available-for-Sale, Current Equity Components [Axis] Equity Components [Axis] Accounts receivable, net Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Sales milestone payment Research and Development Arrangement, Contract to Perform for Others, Sales Milestone Payments Research and Development Arrangement, Contract to Perform for Others, Sales Milestone Payments Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Maturing in one to five years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Estimated fair value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract] Entity Small Business Entity Small Business Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other assets Other Assets, Noncurrent Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued and other current liabilities Total accrued liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Non-cash interest expense Paid-in-Kind Interest Aggregate intrinsic value, exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Shares authorized (in shares) Capital Units, Authorized Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Payment of debt prepayment penalty Payment for Debt Extinguishment or Debt Prepayment Cost Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 7) Commitments and Contingencies Exit fee (as percent) Debt Instrument, Exit Fee, Percentage Debt Instrument, Exit Fee, Percentage Total revenues Total revenues Revenues Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Schedule of Restricted Stock Unit Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Vesting period of stock-based awards granted (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Second Grant Date Second Grant Date [Member] Second Grant Date Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Counterparty Name [Axis] Counterparty Name [Axis] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Remaining contractual term, exercisable (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Inventory Total inventory Inventory, Net Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Consideration transferred, equity interest issued and issuable Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Supplemental Cash Flow Information [Abstract] PEO Name PEO Name Accrued liabilities Increase (Decrease) in Accrued Liabilities Other segment expenses Segment Reporting, Other Segment Item, Amount Concentration of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Other income (expense), net Interest Expense, Debt Cash and cash equivalents and debt securities, available for sale Cash And Cash Equivalents And Debt Securities, Available For Sale, Fair Value Disclosure Cash And Cash Equivalents And Debt Securities, Available For Sale, Fair Value Disclosure Exercised (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Accounts payable Increase (Decrease) in Accounts Payable Accrued expenses and other current liabilities Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Debt Instrument [Axis] Debt Instrument [Axis] First Equity Public Offering First Equity Public Offering [Member] First Equity Public Offering Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense ESPP shares subject to future issuance Employee Stock [Member] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Earnings (loss) per share, basic (in USD per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Long-term debt, net Long-term debt, net Long-Term Debt, Excluding Current Maturities Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Estimated fair value Total marketable securities Debt Securities, Available-for-Sale Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Product milestone payment for first product approval Research and Development Arrangement, Contract to Perform for Others, Product Milestone Payment For First Product Approval Research and Development Arrangement, Contract to Perform for Others, Product Milestone Payment For First Product Approval Cover [Abstract] Equity Awards Adjustments Equity Awards Adjustments [Member] 2022 Equity Incentive Plan 2022 Equity Incentive Plan [Member] 2022 Equity Incentive Plan Asset Acquisition [Line Items] Asset Acquisition [Line Items] Total liabilities and stockholders’ equity Liabilities and Equity Stock Options Stock options to purchase common stock Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Annual net sales Asset Acquisition, Annual Net Sales of Acquiree Threshold Asset Acquisition, Annual Net Sales of Acquiree Threshold Accrued sales deductions Accrued Sales Discounts Accrued Sales Discounts Milestone payment for intangible asset Payments to Acquire Intangible Assets Other income (expense), net Other Nonoperating Income (Expense) Debt Long-Term Debt [Text Block] Name Awards Close in Time to MNPI Disclosures, Individual Name ZORYVE foam ZORYVE Foam [Member] ZORYVE Foam Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate Intrinsic Value ($, in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Stock price (in USD per share) Sale of Stock, Price Per Share Masaru Matsuda, Options Trading Plan [Member] Masaru Matsuda, Options Trading Plan Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adjustment to Compensation: Adjustment to Compensation [Axis] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Interest expense paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets Assets, Fair Value Disclosure Cash, cash equivalents, restricted cash and marketable securities Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalents and Marketable Securities Name Measure Name Schedule of Cash and Cash Equivalents [Table] Cash and Cash Equivalent [Table] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Other non-cash items, net Other Noncash Income (Expense) Debt Instrument [Line Items] Debt Instrument [Line Items] Potential additional payments to be received Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount, Regulatory Milestones Debt Instrument, Tranche [Domain] Debt Instrument, Tranche [Domain] Debt Instrument, Tranche [Domain] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-In Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Other revenue Revenue Not from Contract with Customer Name Trading Arrangement, Individual Name Amortized cost Cash and Cash Equivalent Upfront payment received before taxes Contract Not With Customer, Upfront Payment, Net Contract Not With Customer, Upfront Payment, Net Loan agreement Loan Agreement [Member] Loan Agreement Raw materials Inventory, Raw Materials, Net of Reserves Third Grant Date Third Grant Date [Member] Third Grant Date Company Selected Measure Amount Company Selected Measure Amount Interest rate at end of period Debt Instrument, Interest Rate At Period End Debt Instrument, Interest Rate At Period End Entity Address, Address Line Two Entity Address, Address Line Two Current assets: Assets, Current [Abstract] Masaru Matsuda, Common Stock Trading Plan [Member] Masaru Matsuda, Common Stock Trading Plan Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Provision for income taxes Income Tax Expense (Benefit) Cost of sales Cost of Product and Service Sold Award Timing Method Award Timing Method [Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forecast Forecast [Member] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Maximum borrowing capacity Debt Instrument, Maximum Borrowing Capacity Debt Instrument, Maximum Borrowing Capacity Covenant period Debt Instrument, Funding Availability, Covenant, Period Debt Instrument, Funding Availability, Covenant, Period Segment and consolidated net income (loss) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Prepayment premium (as a percent) Debt Instrument, Prepayment Premium Debt Instrument, Prepayment Premium Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from issuance of common stock upon exercise of stock options Proceeds from Stock Options Exercised Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Certificates of deposit Certificates of Deposit [Member] Interest income Investment Income, Interest Exercisable, Weighted-Average Exercise Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Revenues: Revenues [Abstract] Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]